Management Team

Christopher Ting

DR. CHRISTOPHER TING

GROUP MANAGING DIRECTOR & CEO
EXECUTIVE DIRECTOR, PAH (AUSTRALIA)
  • Co-founder of Pathology Asia
  • Co-founder of Biomark
  • Former CEO of Innovative Diagnostics
  • Founder of Quantum Diagnostics
  • Former CEO of Quest Laboratories and Gribbles Pathology
  • Former Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
  • Clinically trained

 

Nabil_edited_edited_edited

NABIL FAWZI

DEPUTY GROUP CEO
  • Founding CFO of Pathology Asia
  • Over 20 years of corporate experience, including 10 years of Corporate Finance and M&A
  • Previously led EY Asia Pacific’s Healthcare Corporate Finance / M&A as Director of APAC Origination
  • Former Director of Corporate Finance, PwC Singapore
  • Started his career with UEM Group, a subsidiary of Khazanah Nasional Berhad
  • Led and executed over USD10 billion worth of M&A and investment deals across Southeast Asia throughout his career
Rajkumar_edited_edited

RAJKUMAR RENGARAJU

DEPUTY GROUP CEO & GROUP COO
  • Founding Management Team Member of Pathology Asia
  • More than 20 years of experience in the medical laboratory industry
  • Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification
  • Led and managed multiple mergers and laboratory rollout’s
  • Leads Pathology Asia’s drive to operational and reputational excellence.
ChrisSkennerton_edited_edited_edited_edited

CHRIS SKENNERTON

Group CTO
  • Joined Pathology Asia in early 2022
  • Over 30 years in digital innovation and transformation, operations, software engineering and lab information systems
  • Previously with 4Cyte Pathology, Healius, GE Healthcare and the Royal Australian Air Force